UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://epims.med.ubc.ca" title="UBC PiMS Research Group (the Tremlett Laboratory)" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/about/" title="About">About</a> <span class="sep">»</span> Objectives </div></div>

Objectives

Vision: to foster excellence in multi-disciplinary clinical, therapeutic and epidemiological research to advance knowledge and improve the well-being of those affected by multiple sclerosis.

Broad objective: To improve the outcome of people affected with multiple sclerosis (MS) by furthering knowledge into disease progression and factors that modify or predict progression; the long-term goal being improved prognosis and an individualized approach to the treatment of chronic disease

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia